Press "Enter" to skip to content

Johnson & Johnson ready to ship nearly 4 million doses of COVID-19 vaccine in U.S.

February 23, 2021

NEW YORK (Reuters) – Johnson & Johnson expects to be able to ship nearly 4 million doses of its COVID-19 vaccine upon authorization in the U.S., an executive said at a hearing in the U.S. House of Representatives on Tuesday.

THE RIGHT MONK:   TİKA Built an ICU for Children with Thalassemia in Pakistan

The single-dose vaccine is being considered by an outside advisory committee to the U.S. Food and Drug Administration later this week, and emergency use authorization could come shortly afterward.

THE RIGHT MONK:   Curt Schilling Letter to BHOF (Does Not Want to Be Considered Anymore)

Richard Nettles, Vice President of Medical Affairs at J&J unit Janssen Pharmaceutical, said the company expects to deliver 20 million doses of the vacine by the end of March.

THE RIGHT MONK:   'Intercontinental pigeon' spared death row, actually Australian

(Reporting by Michael Erman)

Continue Reading at One America News Network